A Protocol Based Treatment for Early and Severe Systemic Sclerosis With (Anti-CD20), Rituximab
Clinical trial NCT00379431 · COMPLETED
Trial details
- NCT number
- NCT00379431
- Sponsor
- University Hospital, Ghent
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-27
- Primary completion
- 2009-02-02
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.